novo nordisk ceo talks soaring weight-loss drug demand, q1 earnings
Published 6 months ago • 3.6K plays • Length 7:57Download video MP4
Download video MP3
Similar videos
-
1:48
can glp-1 weight-loss drug manufacturers keep momentum up?
-
2:15:10
novo nordisk ceo lars jorgensen testifies before senate on weight loss drugs pricing — 9/24/24
-
25:11
ozempic and wegovy lead novo nordisk to yahoo finance's company of the year
-
5:27
novo nordisk ceo on q4 results, soaring demand for wegovy and ozempic
-
8:56
nvda cash machine giving competitors "run for their money"
-
13:25
is germany headed for a collapse?
-
8:54
how novo nordisk became europe's most valuable company
-
6:48
novo nordisk is scaling wegovy supply 'significantly': cfo
-
12:06
novo nordisk ceo talks weight loss drug supply | bloomberg talks
-
5:20
'attractive' growth ahead for novo nordisk, ceo says
-
1:29
weight loss drugs: novo nordisk stock hits record high on new data
-
4:29
nbc news exclusive: ozempic and wegovy novo nordisk ceo speaks out on high prices, drug shortages
-
4:16
novo nordisk reports q1 profits o $3.65 bn as demand for weightloss drug soars
-
3:32
eli lilly, novo nordisk to test weight loss drugs for children
-
8:32
the glp-1 makers to consider adding to your portfolio: tema etfs ceo
-
4:09
weight loss drug wegovy sales fuel novo nordisk stock performance
-
4:06
weight-loss drug pricing under scrutiny by lawmakers
-
1:00
novo nordisk is yahoo finance’s company of the year #shorts
-
24:07
the ceo behind ozempic, wegovy and europe's most valuable company
-
8:55
high drug prices due to ‘complex health care system’ in the u.s., novo nordisk ceo says
-
2:16
how novo nordisk built an empire selling diabetes and weight-loss drugs
-
4:53
novo nordisk spent $11 million on ozempic promotion